A UAMS research team led by Brian Koss, Ph.D., with first author Sydnye Shuttleworth, has published findings in Cellthat could help advance cancer immunotherapies by addressing a central challenge: keeping immune cells effective against cancer over time.
BioVentures recognizes UAMS innovators and their contributions to advancing research, protecting intellectual property, and bringing new technologies to market.
BioVentures, the technology transfer office of the University of Arkansas for Medical Sciences (UAMS), has partnered with the UAMS Office of Research and Innovation to launch the Research Innovation Ambassadors Program, an initiative designed to strengthen innovation awareness, encourage collaboration and connect researchers with resources and opportunities across UAMS.
Innovation Day 2026, held August 19 at UAMS, brought together more than 100 researchers, clinicians, entrepreneurs, investors, attorneys, and industry leaders to explore how discoveries can move toward real-world impact. Throughout the day, speakers shared insights on funding, intellectual property, regulatory pathways, technology transfer, and commercialization, highlighting the importance of collaboration and practical conversations in advancing innovation. In this new episode, hear recorded highlights from guest speakers featured during the first portion of Innovation Day 2026 and revisit some of the ideas and perspectives that shaped the event. Listen to the episode now.
BioVentures team members joined technology transfer professionals in Charlotte for three days of specialized training and professional development at AUTM University 2026.
BioVentures welcomes 13 researchers to the newest CADET cohort, expanding the program into a year-long commercialization and entrepreneurship experience.
BioVentures celebrates a newly issued patent advancing indole-derived compounds designed to overcome therapeutic resistance in cancer by targeting DNA polymerases.
BioVentures honored UAMS researchers, inventors, students and innovation champions during the Innovation Day 2026 Awards & Recognition Ceremony.
A look back at BioVentures Innovation Day 2026, bringing together the UAMS innovation community for a day of connection, collaboration and recognition.
BioVentures is now accepting applications for the third cohort of the AR Health Ventures Accelerator (ARHVA), a program designed to accelerate promising therapeutic and health-related innovations developed at the University of Arkansas for Medical Sciences (UAMS).
